Cargando…
Doxorubicin Paradoxically Ameliorates Tumor-Induced Inflammation in Young Mice
Doxorubicin (DOX) is one of the most widely used chemo-therapeutic agents in pediatric oncology. DOX elicits an inflammatory response in multiple organs, which contributes to DOX-induced adverse effects. Cancer itself causes inflammation leading to multiple pathologic conditions. The current study i...
Autores principales: | Abdelgawad, Ibrahim Y., Grant, Marianne K. O., Popescu, Flavia E., Largaespada, David A., Zordoky, Beshay N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396671/ https://www.ncbi.nlm.nih.gov/pubmed/34445729 http://dx.doi.org/10.3390/ijms22169023 |
Ejemplares similares
-
Sexual Dimorphism in Doxorubicin-induced Systemic Inflammation: Implications for Hepatic Cytochrome P450 Regulation
por: Grant, Marianne K.O., et al.
Publicado: (2020) -
Metformin mitigates SASP secretion and LPS-triggered hyper-inflammation in Doxorubicin-induced senescent endothelial cells
por: Abdelgawad, Ibrahim Y., et al.
Publicado: (2023) -
Sexual dimorphism of acute doxorubicin-induced nephrotoxicity in C57Bl/6 mice
por: Grant, Marianne K. O., et al.
Publicado: (2019) -
Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology
por: Abdelgawad, Ibrahim Y., et al.
Publicado: (2019) -
Exposure to Doxorubicin Modulates the Cardiac Response to Isoproterenol in Male and Female Mice
por: Agostinucci, Kevin, et al.
Publicado: (2023)